Contact Information
  • 800-826-HOPE (4673)
Robert J. Morgan, Jr., M.D., F.A.C.P.
  • Professor
  • Co-director Gynecological Cancers Program
  • Co-director, Gynecological Oncology/Peritoneal Malignancy Program
  • Director, Continuing Medical Education
  • Associate Director for Medical Education, Medical Oncology & Therapeutics Research
  • Director of Interdisciplinary Education, Sheri & Les Biller Patient and Family Resource Center

Languages Spoken
  • Italian
  • English

Professional Experience

  • 2004 - present, Professor of Medical Oncology, Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA
  • 2001 - present, Assistant Clinical Professor of Medicine, UCLA Medical School, Los Angeles, CA
  • 1988 - present, Staff Physician, Department of Medical Oncology and Therapeutics Research. City of Hope, Duarte, CA
  • 1987 - 1988, Fellow, Department of Medical Oncology and Therapeutics Research. City of Hope, Duarte, CA
  • 1986 - 1987, Research Fellow, Department of Hematology. Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN
  • 1984 - 1986, Fellow, Department of Hematology. Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN
  • 1981 - 1984, Resident, Internal Medicine. Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN

Education

Education/Training
  • 1974 - 1978, Universita degli Studi di Perugia Facolta di Medicina e Chirurgia, Perugia, Italy
  • 1974, Universita per Straneiri, Perugia, Italy. Italian Language Certificate (speak, read and write Italian)
  • 1970 - 1974, Loyola University, Chicago, Illinois. B.S. Biology

Board Certifications/Licensure
  • 1978 - 1981, University of Illinois College of Medicine. Peoria School of Medicine, Peoria, Illinois. Doctor of Medicine
  • 1989, Board Certified in Medical Oncology
  • 1987, State of California, License
  • 1986, Board Certified in Hematology
  • 1984, Board Certified in Internal Medicine
  • 1982, Controlled Substance Registration

Honors/Awards

Awards
  • 1992, Fellow of the American College of Physicians
  • 1981, University of Illinois Medical Alumni Association Leadership Award
  • 1980, Smith-Kline Award for Excellence in Pathology and Laboratory Medicine
  • 1980, Research Award from Illinois Valley Lung Association

Memberships

  • American Society of Clinical Oncology
  • Southwest Oncology Group
  • National Surgical Adjuvant Breast and Bowel Project
  • Gynecologic Oncology Group
  • Society for Neurooncology
  • Southern California Academy of Clinical Oncology

Publications

  • Lowe, T and Morgan, RJ. Intraperitoneal Chemotherapy of Ovarian Cancer: A Review. Women's Health, 3(4): 433-440 2007.
  • Shibata, S., Chow, W., Frankel, P., Juhasz, A., Koczywas, M., Leong, L., Lim, D., Margolin, K., McNamara, M., Morgan, R., Newman, E., Somlo, G., Twardowski, P., Yen, Y., Synold, T., and Doroshow, J. A Phase I study of oxaliplatin in combination with gemcitabine: Correlation of clinical outcome with gene expression. Cancer Chemother Pharmcol 59 (4): 549-557, 2007.
  • Morgan, R.J., Synold, T.W., Xi, B., Lim, D., Shibata, S., Margolin, K., Schwarz, R.E., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Tetef, M., Lin, P., Paz, B., Koczywas, M., Wagman, L., Chu, D., Frankel, P., Stalter, S., Doroshow, J.H. Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity. Clinical Cancer Research 13(4): 1232-1237, 2007.
  • Morgan, R.J., Jr., Synold, T.W., Gandara, D., Muggia, F., Scudder, S., Reed, E., Margolin, K., Raschko, J., Leong, L., Shibata, S., Tetef, M., Vasilev, S., McGonigle, K., Longmate, J., Yen, Y., Chow, W., Somlo, G., Carroll, M. and Doroshow, J.H. Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: A California Consortium Trial. Int. J Gynecol Cancer 2:373-8, 2007.
  • Morgan, R., Leong, L., Kagan, J., Ball, T., Sanchez, F. Addressing Underserved Topics: A Continuing Medical Education (CME Challenge). Proceedings of American Assoc Cancer Education (AACE), 2006 (Abstract and presentation).
  • Greer, B.E., Koh, W.J., Abu-Rustum, N., Bookman, M.A., Bristow, R.E., Campos, S., Cho, K.R., Copeland, L, Eifel, P., Jaggernauth, W., Jhingran, A., Kapp, D.S., Kavanagh, J., Lipscomb, G.H., Lurain, JR 3rd, Morgan, R.J. Jr., Nag, S., Partridge, E.E,. Powell, C.B., Remmenga, S.W., Reynolds, R.K., Small, W., Jr., Soper, J., Teng, N. Uterine cancers. J Natl Compr Canc Netw 4(5): 438-62, 2006.
  • Morgan, R.J., Jr., Alvarez, R.D., Armstrong, D.K., Chen, L.M., Copeland, L., Fowler, J., Gaffney, D.K., Gershenson, D., Greer, B.E., Johnston, C., Lancaster, J.M., Lele, S., Matulonis, U., Ozols, R.F., Remmenga, S.W., Sabbatini, P., Soper, J., Teng, N. Ovarian cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 4(9): 912-39, 2006.
  • Openshaw, H., Beamon, K., Synold, T.W., Longmate, J., Slatkin, N.E., Doroshow, J.H., Forman, S., Margolin, K., Morgan, R., Shibata, S., and Somlo, G. The effect of height on paclitaxel nerve damage. J. Neurooncology 74: 207-210, 2005.
  • Lim, D.W., Morgan, R.J., Jr., Akman, S., Margolin, K., Carr, B.I., Leong, L., Odujinrin, O., and Doroshow, J.H. Phase I trial of menadiol diphosphate (Vitamin K3) in advanced malignancy. Investigational New Drugs 23: 235-239, 2005.
  • Morgan, R.J., Jr., Synold, T.W., Gandara, D., Muggia, F., Scudder, S., Reed, E., Margolin, K., Raschko, J., Leong, L., Shibata, S., Tetef, M., Vasilev, S., McGonigle, K., Longmate, J., Yen, Y., Chow, W., Somlo, G., Carroll, M., and Doroshow, J.H. Phase II trial of carboplatin and infusional cyclosporine in refractory recurrent ovarian cancer. Cancer Chemother. Pharmacol. 54: 283-289, 2004.
  • Somlo, G., Frankel, P., Chow, W., Leong, L., Margolin, K., Morgan, Jr., R., Shibata, S., Chu, P., Forman, S., Lim, D., Twardowski, P., Weitzel, J., Alvarnas, J., Kogut, N., Schriber, J., Fermin, E., Damon, L. and Doroshow, J.H. Prognostic indicators and survival in 120 patients with stage IIIB inflammatory breast carcinoma following dose-intense chemotherapy. J. Clin. Oncol. 22: 1839-1848, 2004.
  • Shibata, S.I., Lin, S., Dorohsow, J.H., Pezner, R., Chow, W.A., Leong, L.A., Margolin, K.A., McNamara, M.V., Morgan, R.J., Jr., Raschko, J.W., Somlo, G., Tetef, M.L., Yen, Y., Synold, T.W., Pezner, R., Chu, D., Wagman, L., Vora, N., Carroll, M., Lee, S., and Longmate, J. Pilot study of intraoperative and external beam radiation therapy combined with continuous infusion 5-fluorouracil in locally advanced gastrointestinal malignancies. Eur. J. Surg. Oncol. 30: 650-657, 2004.
  • Morgan, R.J., Jr., Doroshow, J.H., Synold, T., Lim, D., Shibata, S., Margolin, K., Schwarz, R., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Lin, P., Paz, B., Chu, D., Frankel, P., and Stalter, S.: Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies confined to the peritoneal cavity: Dose-limiting toxicity ad pharmacokinetics. Clin. Cancer Res. 9: 5896-5901, 2003.
  • Morgan, R.J., Jr., Newman, E., Sowers, L., Scanlon, K., Harrison, J., Akman, S., Leong, L., Margolin, K., Niland, J., Raschko, J., Somlo, G., Carroll, M., Chow, W., Tetef, M., Hamasaki, V., Yen, Y., and Doroshow, J.H. Phase I Study of cis-diamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies. Cancer Chemother. Pharmacol. 51: 459-464, 2003.
  • Morgan, R., Hetrick, V., Leong, L., Grant, M., Pritt, B. Divergence of perceived educational needs as viewed by physicians vs. health care consumers: Potential impact on continuing medical education (CME) planning. J Cancer Education (3) 16: 34-35, 2001. (AACE 35th Annual Meeting Program) .
  • Morgan, R.J., Jr., Doroshow, J.H., Leong, L., Schriber, J., Shibata, S., Forman, S., Hamasaki, V., Margolin, K., Somlo, G., Alvarnas, J., McNamara, M., Longmate, J., Raschko, J., Chow, W., Vasilev, S., McGonigle, K., and Yen, Y. Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer. Blood Marrow Transplant. 28: 159-183, 2001.
  • Morgan, R.J., Synold, T.W., Carr, B.I., Doroshow, J.H., Womack, E.P., Shibata, S., Somlo, G., Raschko, J.W., Leong, L., McNamara, M., Chow, W., Tetef, M.L., Margolin, K., Akman, S., and Longmate, J. Continuous infusion prochlorperazine: Pharmacokinetics, anti-emetic efficacy, and feasibility of high-dose therapy. Cancer Chemother. Pharmacol. 47: 327-332, 2001.
  • Morgan, R.J. Jr., Braly, P., Leong, L., Shibata, S., Margolin, K., Somlo, G., McNamara, M., Longmate, J., Schinke, S., Raschko, J., Nagasawa, S., Kogut, N., Najera, L., Johnson, D., and Doroshow, J.H. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously-treated patients with advanced ovarian cancer: Long-term follow-up. Gynecol. Oncol. 77: 433-438, 2000.
  • Morgan RJ Jr, Braly P, Cecchi G, Leong L, Shibata S, Margolin K, Somlo G, McNamara M, Longmate J, Schinke S, Raschko J, Nagasawa S, Kogut N, Parker P, Stein A, Cho J, Smith E, Coluzzi P, Najera L, Johnson D, Womack E, Doroshow JH. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up. Gynecol Oncol. 1999 Dec;75(3):419-26.

Locations

  • City of Hope - Main Campus (Duarte)
    1500 East Duarte Road
    Duarte, CA 91010